PPAD: A deep learning architecture to predict progression of Alzheimer’s disease

Mostrar otras versiones (1)

Alzheimer’s disease (AD) is a neurodegenerative disease that affects millions of people worldwide. Mild cognitive impairment (MCI) is an intermediary stage between cognitively normal (CN) state and AD. Not all people who have MCI convert to AD. The diagnosis of AD is made after significant symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Olaimat, Mohammad, Martinez, Jared, Saeed, Fahad, Bozdag, Serdar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915480/
https://www.ncbi.nlm.nih.gov/pubmed/36778453
http://dx.doi.org/10.1101/2023.01.28.526045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915480/
https://www.ncbi.nlm.nih.gov/pubmed/36778453
http://dx.doi.org/10.1101/2023.01.28.526045

Ejemplares similares